Interní Med. 2010; 12(9): 442-444

Treatment of ischemic stroke

doc.MUDr.Jiří Bauer, CSc.
Neurologická klinika 1. LF UK a VFN Praha

Stroke is an emergency, stroke victims must be admitted without delay to the hospital. All stroke patients should be treated in primary

or comprehensive stroke centers. Basis of care is general treatment, including intensive rehabilitation. Another treatment is strongly

individual. Treatment of ischeamic stroke is focused on recanalisation therapy, early prevention, therapy and prevention of secondary

brain injury.

Keywords: stroke, stroke centrum, general treatment, thrombolytic therapy

Published: October 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bauer J. Treatment of ischemic stroke. Interní Med. 2010;12(9):442-444.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mosley I, Nicol M, Donnan G, et al. Stroke symptoms and decision to call for an ambulance. Stroke 2007; 38: 361-366. Go to original source... Go to PubMed...
    2. Norrving B, Adams RJ. Organized stroke care. Stroke 2006; 37: 326-328. Go to original source... Go to PubMed...
    3. Update Guidelines January 2009 New Elements. Available from: URL:/http://www.esostroke.org/pdf/ESO_Extended_Thrombolysis_KSU.pdf.
    4. Protokol trombolytické terapie. Cerebrovaskulární sekce České neurologické společnosti JEP. www.cmp.cz. Dostupné na: http://www.cmp.cz/.
    5. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507. Go to original source... Go to PubMed...
    6. Wahlgren N, Ahmed A, Eriksson N, et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials; Safe Implementation of Thrombolysis in Stroke Monitoring Study (SITS-MOST). Stroke 2008; 39: 3316-3322. Go to original source... Go to PubMed...
    7. Mayer SA, Schwab S. Critical Care and emergency medicine. Stroke 2007; 38: 225-228. Go to original source... Go to PubMed...
    8. Bauer J. Trombolytická terapie ischemického iktu. Postgraduální medicína 2009; 11(8): 906-912.
    9. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587.
    10. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3-4.5 hours after acute ischemic stroke. New Engl J Med 2008; 359: 1317-1329. Go to original source... Go to PubMed...
    11. Wahlgren N, Ahmed A, Dávalos A, et al. Thrombolysis with alteplase 3-4,5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008; 372: 1303-1309. Go to original source... Go to PubMed...
    12. IMS investigators: The interventional Management of Stroke (IMS) II study. Stroke 2007; 38: 2127-2135. Go to original source... Go to PubMed...
    13. Smith WS, Sung G, Budzik R, et al. Mechanical thrombectomy for acute ischemic stroke. Stroke 2008; 39: 1205-1212. Go to original source... Go to PubMed...
    14. Vahedi K, Hofmeijer J, Jüttler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6: 215-222. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.